Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359720180360040329
Journal of the Korean Neurological Association
2018 Volume.36 No. 4 p.329 ~ p.332
Rituximab Treatment for Polyneuropathy Induced by an Immune Checkpoint Inhibitor
Shin Hye-Rim

Kang Dong-Wan
Kim Eun-Young
Kim Tae-Min
Lee Soon-Tae
Abstract
Immune checkpoint inhibitor is associated with variety of immune-related adverse events. We present a case of polyneuropathy induced by immune checkpoint inhibitor, which was refractory to steroid and immunoglobulin. While high-dose steroid and immunoglobulin were not effective, we tried rituximab which is effective in other immune-mediated polyneuropathy. After rituximab treatment, patient¡¯s clinical symptom and nerve conduction study finding was markedly improved. We suggest rituximab might be effective in polyneuropathy induced by immune checkpoint inhibitor.
KEYWORD
Autoimmune diseases, Polyneuropathies, Rituximab
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø